TheBodyPro

The HIV resource for care providers and the HIV workforce.
For the HIV community, check out @TheBodyDotCom

[TheBodyPro @BodyPROHIV]

Can dolutegravir/lamivudine be just as effective in people with archival M184V/I as it is in everyone else? A new #study published in @CIDJournal gets us as close as we’ve ever been to a firm answer: https://t.co/CnGLY2I2eW

#HIV #Research #Medicine

[TheBodyPro @BodyPROHIV]

As people with #HIV live longer on viral suppression, parkinsonism‑like motor symptoms are increasingly recognized and may affect quality of life. A recent review in @TheLancet highlights why awareness of these changes matters for #aging with HIV: https://t.co/zLRevrDX82

[TheBodyPro @BodyPROHIV]

Recorded during a pivotal moment for #HIV care, @UNC_ID's Dr. Wohl unpacks the top #clinical and policy developments shaping the field, and what they mean for prevention, treatment, and equity moving forward.

A must-listen for HIV clinicians: https://t.co/Kkx3cgrDNX

#HIVCare

[TheBodyPro @BodyPROHIV]

New #data affirm the value of #pneumonia and herpes zoster #vaccination for particular subsets of people living w/ #HIV — and of the continued relevance of these infectious diseases.

Dr. Young shares the three key #clinical lessons #HCPs need to know: https://t.co/7OCtH1azR9

[TheBodyPro @BodyPROHIV]

A two-year #study comparing two forms of #PrEp found small but significant differences in BMD impact. The findings provide a golden opportunity for #HCPs to revisit what we know about BMD, and how we can best approach conversations with our patients: https://t.co/o7xKGyJfAi

#HIV

[TheBodyPro @BodyPROHIV]

While we’ve long known that starting #ART early benefits long-term #health, a recent #study makes the scale of that impact clear: people starting within a year of #HIV acquisition are roughly 40% less likely to develop non-AIDS #cancers. https://t.co/2dBaPyJaEb

#Medicine

[TheBodyPro @BodyPROHIV]

#TelePrEP is growing fast. According to a new study in @JAMANetworkOpen, ~19% of U.S. #PrEP users received care virtually in 2024. Dr. Young highlights three key takeaways about scale, access for uninsured/first-time users, and patient preference: https://t.co/CmCC4SIHC9

#HIV

[TheBodyPro @BodyPROHIV]

As #HIV prevention options expand, choosing the right #PrEP isn’t just about efficacy. In a new interview, Dr. Anu Hazra (@UChicagoMed + @howardbrownhc) explains the best choice is the one that aligns with your patient’s needs, preferences, and lifestyle:
https://t.co/i04GJ2q3uB

[TheBodyPro @BodyPROHIV]

We care deeply for our patients, but who’s caring for #HIV care teams? A new #study shows #resilience alone doesn’t shield care teams from the impact of trauma. Dr. Benjamin Young breaks down what providers need: https://t.co/GyJ5vHjbOb

#MentalHealth #Medicine #HCP #HIVCare

[TheBodyPro @BodyPROHIV]

As #HIV providers, we can’t ignore this: Cancer screening rates remain low for Black women with HIV. Engagement in care isn’t enough. Dr. Benjamin Young challenges us to examine our role in closing the gap: https://t.co/qL1WIxd3UE

#Research #Medicine #CancerScreening

[TheBodyPro @BodyPROHIV]

Amid rising threats to #HIV #funding and community #health, @prepinblkUS is launching the PrEP in Black America HIV Policy Impact Tracker this spring. What to know: https://t.co/RXGG64NohI

#HIV #HIVCare #CommunityHealth

[TheBodyPro @BodyPROHIV]

Could a two-drug combo simplify #HIV treatment? ARTISTRY-1 results are intriguing, but experts urge caution.

Dr. Benjamin Young and @BodyProHIV’s Myles Helfand explain: https://t.co/H5W9xXY1O4

#HIVCare #ART #HIVResearch

[TheBodyPro @BodyPROHIV]

Injectable, twice-yearly #PrEP makes prevention easier, but knowing how to use it matters.

@JncherabieMD shares key insights on injectable #lenacapavir, from dosing to how to talk about it with patients: https://t.co/owujGGv4bV

#HIV #HIVPrevention #HIVCare

[TheBodyPro @BodyPROHIV]

What do people wish they’d heard after an #HIV diagnosis? One person's reflection shows how small changes in communication can make a big difference: https://t.co/IQ9AV6JEC5

#HIV #Medicine

[TheBodyPro @BodyPROHIV]

Many patients with #HIV experience disordered #sleep that’s easy to miss. Drs. Chandiwana and Scheuermaier explain how to recognize distinct HIV-related sleep patterns and when to refer: https://t.co/F8noDcjxP0

#HIVCare #SleepMedicine

[TheBodyPro @BodyPROHIV]

People with substance use face a higher #HIV risk, yet new data show that many treatment settings still don’t offer routine HIV testing, #PrEP, or care services.

How can we better integrate these services for the communities who need them most?

More: https://t.co/HZPdVcDf8x

[TheBodyPro @BodyPROHIV]

Regardless of your role in #HIV care, many of us are feeling the strain of the moment. In the latest Future of HIV Care #podcast, Dr. Young reflects on what matters most now and how #HCPs can stay grounded while serving their #patients and communities: https://t.co/xMXZxkT934

[TheBodyPro @BodyPROHIV]

For #HCPs who don't consider pet ownership as a health factor among our patients, it’s time we evolve that thinking.

New @UF study reveals strong evidence supporting a clear association between viral suppression and pet ownership among people with #HIV: https://t.co/FpzlUDruZh

[TheBodyPro @BodyPROHIV]

Stigma in #HIV care often starts with language. People‑first terminology promotes dignity, accuracy and better patient rapport. Phrases to retire and what to say instead: https://t.co/OxHCSARsWw

#HIVCare #Medicine #HCP

[TheBodyPro @BodyPROHIV]

As people living with HIV age, #frailty is increasingly recognized as a significant threat to overall #wellness. Test your knowledge with these four questions on key concepts related to frailty assessment and its implications for #HIV care: https://t.co/gYiMF7Uigy